Bromocriptine: all 28 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyRecruitingNCT05180773Phase 4
- Bromocriptine for Patients With Schizophrenia and PrediabetesNot yet recruitingNCT03575000Phase 4
- Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia NervosaCompletedNCT04128683Early Phase 1Results posted
- Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic InjuryCompletedNCT03496545Phase 1/2Results posted
- Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes SubjectsCompletedNCT02682901Phase 4Results posted
- Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 DiabetesCompletedNCT02544321Phase 2Results posted
- Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue TherapyCompletedNCT02299050Phase 4Results posted
- Efficacy and Safety of Cycloset® Compared With Placebo When Added to MetforminTerminatedNCT00441363Phase 3Results posted
- Safety and Tolerability Study of Cycloset in Treatment of Type 2 DiabetesCompletedNCT00377676Phase 3Results posted
- Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's DiseaseCompletedNCT04413344Phase 1/2
- Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid ResponseCompletedNCT04351126Phase 2
- Satisfaction of Patients With the Chosen Method of Inhibition of LactationStatus unknownNCT04038749Not applicable
- Dopamine Action on Metabolism in Relation to GenotypeCompletedNCT03525002Phase 2
- Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DMEWithdrawnNCT03384524Phase 1/2
- Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT InhibitorWithdrawnNCT02929485Phase 4
- Bromocriptine in the Treatment of Peripartum CardiomyopathyWithdrawnNCT02590601Phase 3
- Bromocriptine and Insulin SensitivityCompletedNCT02428946Not applicable
- Dopaminergic Effects on Brown Adipose TissueCompletedNCT02428933Not applicable
- To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related ParkinsonismCompletedNCT02265484Not applicable
- Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's DiseaseCompletedNCT02172573Phase 3
- Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot StudyStatus unknownNCT02133755Phase 3
- Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus SubjectsCompletedNCT02078440Phase 1
- Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune TreatmentTerminatedNCT01893450Not applicable
- Vaginal Bromocriptine for Treatment of AdenomyosisCompletedNCT01821001Phase 1
- Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum CardiomyopathyCompletedNCT00998556Phase 2
- The Therapeutic Effect of Bromocriptin in Patients With Primary AldosteronismStatus unknownNCT00451672Phase 4
- Risperidone-Induced Hyperprolactinemia Treated With BromocriptineStatus unknownNCT00315081Phase 3
- Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's DiseaseCompletedNCT00240409Phase 3